Andrew Partheniou
Recent Articles
Biotech Co. Makes Strides on Three Fronts 09/19/2023
This Canadian firm sold assets, launched an equity raise and filed a clinical trial application for its lead psychedelic-assisted psychotherapy program, noted a Stifel report.
Recent Quotes
"AWKN announced its first KARE licensing agreement."
—
Andrew Partheniou, Stifel
(8/15/22)
more >
"AWKNF shares offer an attractive risk-reward profile."
—
Andrew Partheniou, Stifel
(3/31/22)
more >
Due to permission requirements, not all quotes are shown.
